Want to join the conversation?
$IR 2Q15 Call: On a reported basis our continuing EPS was $0.31. Orders for 2Q15 were up 2% on a reported basis and up 6% excluding FX. On an organic basis which excludes both FX and acquisitions orders were up 4%. Climate orders were up 3% and up 6% excluding FX. Orders in industrial segment were down 1% on a reported basis & up 5% excluding FX.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.